IMP-A-SDB Implantica AG

66.00SEK-2.94%Mkt Cap: —P/E: —

Implantica AG engages in the research and distribution of medical implants in Switzerland and Spain. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal refl…

Key Statistics

Company
Market Cap—
Enterprise Value1.84B USD
Revenue (TTM)236.17K USD
Gross Profit-17.60K USD
Net Income (TTM)-1.89M USD
Revenue/Share0.0090 SEK
Last Price66.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees46
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0014855029
Valuation
P/E (Trailing)—
P/E (Forward)-17.66
PEG—
EV/EBITDA-966.32
EV/Revenue7786.91
P/S—
P/B248.18
EPS (TTM)-0.06
EPS (Forward)-3.85
52W Range
38.0066% of range80.30
52W High80.30 SEK
52W Low38.00 SEK
Profitability
Gross Margin-7.45%
Oper. Margin-585.77%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-23.65%
ROA-14.30%
Growth
Revenue Growth65.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.50M USD
CapEx (TTM)—
FCF Margin-383.39%
FCF Yield—
Net Debt-3.97M USD
Net Debt/EBITDA2.09
Balance Sheet
Debt/Equity0.25
Current Ratio14.69
Quick Ratio14.57
Book Value/Sh0.27 SEK
Cash/Share0.15 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)91.60 SEK
Upside (mean)+38.8%
Target Range91.60 SEK – 91.60 SEK
# Analysts1
Ownership
Shares Out.—
Float29.83M
Insiders0.00%
Institutions12.47%
Technical
SMA 5059.67 (+10.6%)
SMA 20053.07 (+24.4%)
Beta0.65
S&P 52W Chg16.45%
Avg Vol (30d)94.03K
Avg Vol (10d)124.97K
Technical Indicators
RSI (14)54.6
MACD2.9259
MACD Signal2.2848
MACD Hist.+0.6410
BB Upper75.19 SEK
BB Middle63.55 SEK
BB Lower51.90 SEK
BB Width36.64%
ATR (14)3.883 SEK
Vol Ratio (20d)0.44x